The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

BTOG 2019 | Single-port VATS for NSCLC: outcomes related to smoking status

Name: Single-port VATS for NSCLC: outcomes related to smoking status
Uploaded: 2019-01-25T00:00:00Z
Duration: 3 min 36 s
Description: Speaking from the British Thoracic Oncology Group (BTOG) 2019 Annual Conference in Dublin, Ireland, John Edwards, MBChB, PhD, FRCS, of the Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK, discusses clinical outcomes related to smoking status in the era of single-port VATS resection for non-small cell lung cancer (NSCLC).

John Edwards • 25 Jan 2019

BTOG 2019

Lung Cancer Non-Small Cell Lung Cancer

Speaking from the British Thoracic Oncology Group (BTOG) 2019 Annual Conference in Dublin, Ireland, John Edwards, MBChB, PhD, FRCS, of the Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK, discusses clinical outcomes related to smoking status in the era of single-port VATS resection for non-small cell lung cancer (NSCLC).